By Counterforce Health Team in Besponsa (inotuzumab ozogamicin) —

Do You Qualify for Besponsa Coverage by Cigna in Illinois? Decision Tree & Appeal Guide

Answer Box: Your Path to Besponsa Coverage in Illinois

Yes, you likely qualify if you have CD22-positive relapsed/refractory B-cell precursor ALL after failing at least one prior therapy. Cigna requires prior authorization using their Besponsa CCRD form. First step today: Confirm CD22 positivity in your pathology report and gather prior treatment records. If denied, Illinois gives you 4 months to file an external review through the Illinois Department of Insurance. Average approval time: 5 business days for standard review.

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible" - Your Action Plan
  4. If "Possibly Eligible" - Tests to Request
  5. If "Not Yet" - Alternative Options
  6. If Denied - Illinois Appeal Path
  7. Coverage at a Glance
  8. Common Denial Reasons & Fixes
  9. FAQ

How to Use This Decision Tree

This guide helps you and your clinical team determine whether you qualify for Besponsa (inotuzumab ozogamicin) coverage through Cigna in Illinois, then provides the fastest path to approval.

Start here: Answer the questions in Section 2 to determine your eligibility category, then jump to the corresponding action section. Each path includes specific forms, timelines, and next steps based on current Cigna policies and Illinois insurance law.

Eligibility Triage: Do You Qualify?

Answer these questions based on your medical records:

Diagnosis Confirmed?

  • ✓ Yes: CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) documented in pathology/flow cytometry
  • ? Maybe: ALL diagnosis but CD22 status unknown or negative
  • ✗ No: Different type of leukemia or lymphoma

Disease Status?

  • ✓ Yes: Relapsed or refractory disease after at least one prior therapy
  • ? Maybe: Recently diagnosed, considering as first-line therapy
  • ✗ No: Complete remission, no prior treatment failure

Prior Therapy Documentation?

  • ✓ Yes: Clear records of previous regimens (dates, drugs, responses)
  • ? Maybe: Some treatment history but incomplete records
  • ✗ No: No prior standard chemotherapy documented

Age & Performance Status?

  • ✓ Yes: Adult (≥18) with adequate performance status
  • ? Maybe: Pediatric patient or significant comorbidities
  • ✗ No: Poor performance status precluding treatment

Your Result:

  • All ✓: Likely Eligible → Go to Section 3
  • Mix of ✓ and ?: Possibly Eligible → Go to Section 4
  • Any ✗: Not Yet → Go to Section 5

If "Likely Eligible" - Your Action Plan

You meet Cigna's basic criteria. Here's your step-by-step approval path:

Step 1: Gather Required Documentation

Complete this checklist before submitting your prior authorization:

Medical Records:

  • Pathology/flow cytometry report showing CD22-positive B-cell precursor ALL
  • ICD-10 diagnosis code (typically C91.00 for B-cell ALL in relapse)
  • Complete prior treatment history with dates and responses
  • Current CBC, comprehensive metabolic panel, and liver function tests
  • ECOG performance status documentation

Insurance Information:

  • Current Cigna insurance card and member ID
  • Verify medical benefit coverage (Besponsa uses J-code J9229)
  • Confirm Accredo or preferred specialty pharmacy

Step 2: Complete Cigna's Prior Authorization Form

Use Cigna's dedicated Besponsa CCRD Prior Authorization Form. Key sections include:

  • Patient demographics and insurance information
  • Diagnosis confirmation (check "CD22-positive" box)
  • Disease status (check "relapsed or refractory" box)
  • Prior regimens and treatment history
  • Requested dose, quantity, and duration
  • Site of care and dispensing pharmacy

Step 3: Submit Your Request

Preferred Methods:

  • Online: CoverMyMeds portal or EHR-integrated Surescripts
  • Fax: 855-840-1678 (number from current Cigna form)
  • Phone for urgent cases: Use Cigna's PA phone line for expedited review

Timeline: Standard review completed within 5 business days. Mark "urgent" if delay could seriously jeopardize your health.

From our advocates: We've seen the strongest approvals when oncologists include a brief letter explaining why Besponsa is the optimal bridge to transplant, citing the INO-VATE study's 81% response rate versus 29% with standard chemotherapy. This clinical context often resolves medical necessity questions before they become denials.

If "Possibly Eligible" - Tests to Request

You may qualify but need additional documentation. Request these tests and information:

If CD22 Status Unknown

  • Order: Flow cytometry or immunohistochemistry for CD22 expression
  • Timeline: Results typically available in 3-5 business days
  • Coverage note: Cigna requires CD22-positive status; negative results may require alternative therapies

If Prior Therapy History Incomplete

  • Gather: Complete treatment records from all prior oncologists
  • Include: Drug names, doses, start/stop dates, best response, reason for discontinuation
  • Timeline: Allow 1-2 weeks to obtain records from multiple facilities

If Performance Status Unclear

  • Document: Current ECOG performance status assessment
  • Include: Recent imaging, labs, and functional status evaluation
  • Note: Most payers require ECOG ≤2 for Besponsa coverage

Re-apply Timeline: Once you have complete documentation, return to Step 1 in Section 3.

If "Not Yet" - Alternative Options

If you don't currently meet Cigna's criteria, consider these approaches:

For Non-CD22-Positive ALL

  • Alternative: Blinatumomab (targets CD19, not CD22)
  • Coverage: Often easier to obtain for CD19-positive B-cell ALL
  • Next steps: Discuss with your oncologist about CD19 expression testing

For First-Line Treatment Consideration

  • Standard approach: Complete at least one standard induction regimen first
  • Exception pathway: Document contraindications to standard therapy
  • Timeline: Most patients become eligible after first relapse or refractory response

For Poor Performance Status

  • Improve status: Optimize supportive care and comorbidity management
  • Alternative: Consider lower-intensity regimens or clinical trials
  • Re-evaluation: Reassess eligibility in 2-4 weeks

If Denied - Illinois Appeal Path

Illinois provides strong patient rights for insurance appeals. Here's your roadmap:

Internal Appeal (First Step)

Timeline: File within 180 days of denial notice Process: Submit appeal through Cigna member portal or written request Decision deadline: 15 business days for pre-service requests, 24 hours if expedited Success factors: Address specific denial reason, provide missing documentation

External Review (If Internal Appeal Fails)

Illinois' Health Carrier External Review Act gives you powerful appeal rights:

Timeline: 4 months from final adverse determination to request external review Expedited option: Available if delay would seriously jeopardize health Process: Independent physician reviewer evaluates your case Decision: Binding on Cigna if reversed Cost: Free to you; Illinois insurers pay review costs

When to Request Expedited Review

Consider expedited external review if:

  • Delay would make treatment significantly less effective
  • You're still hospitalized or need immediate care
  • Besponsa is labeled "experimental/investigational" in the denial
Tip: Illinois has a stricter 30-day deadline for external review compared to other states' 4-month windows, so act promptly after receiving your final denial.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Besponsa requests Cigna provider portal Cigna PA Requirements
CD22-Positive Must be documented in pathology Flow cytometry report Besponsa PA Form
Relapsed/Refractory After ≥1 prior therapy failure Treatment history notes Besponsa PA Form
J-Code J9229 for medical benefit billing Billing department Medicare Drug List
Appeal Deadline 4 months for external review Final denial letter Illinois External Review

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documents
"CD22 status not documented" Submit flow cytometry report Pathology report showing CD22+
"Not relapsed/refractory" Provide treatment history Prior regimen records with responses
"Experimental/investigational" Cite FDA approval and guidelines FDA label, NCCN references
"Medical necessity not established" Letter from oncologist Clinical rationale for Besponsa vs alternatives
"Missing hepatic monitoring plan" Document VOD monitoring protocol Liver function monitoring schedule

FAQ

How long does Cigna prior authorization take in Illinois? Standard review: 5 business days. Expedited review: 24 hours if delay could seriously jeopardize health. Source: Cigna PA Process

What if Besponsa is non-formulary on my plan? Request a formulary exception through Cigna's standard process. Include medical necessity documentation and evidence that formulary alternatives are inappropriate.

Can I request an expedited appeal in Illinois? Yes, if delay would seriously jeopardize your life, health, or ability to regain maximum function. Illinois requires expedited external review decisions within 72 hours.

Does step therapy apply if I've failed therapies outside Illinois? Yes, prior therapy failures from any state count toward meeting step therapy requirements, as long as you have complete documentation.

What's the difference between internal and external review? Internal appeals are decided by Cigna. External review uses an independent physician reviewer chosen through the Illinois Department of Insurance - and their decision is binding on Cigna.

How much does Besponsa cost without insurance? Wholesale acquisition cost is approximately $8,700 per 0.9mg vial. Total treatment costs vary by number of cycles and dosing. Check with Pfizer's patient assistance programs for potential savings.

At Counterforce Health, we help patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned to your specific payer's requirements, pulling the right clinical evidence and regulatory citations to maximize approval rates.

Whether you're navigating Cigna's prior authorization process or preparing for an Illinois external review, having the right documentation and appeal strategy makes all the difference. If you need additional support with your Besponsa coverage journey, Counterforce Health can help streamline the process and improve your chances of approval.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeal processes. It is not medical advice and should not replace consultation with your healthcare provider. Always verify current policy requirements with your specific Cigna plan and consult with your oncology team about the most appropriate treatment options for your individual situation. For personalized assistance with Illinois insurance appeals, contact the Illinois Department of Insurance at 877-527-9431.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.